Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-085595
Filing Date
2025-06-12
Accepted
2025-06-12 17:33:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 12509
  Complete submission text file 0000950170-25-085595.txt   14227
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Subject) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93233 | Film No.: 251043954
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105
Business Address 455 MARKET STREET, SUITE 1420 SAN FRANCISCO CA 94105 (424) 313-1550
Vida Ventures GP III, L.L.C. (Filed by) CIK: 0001855502 (see all company filings)

EIN.: 861852530 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A